Drugs of Abuse Testing Assays
6-Acetylmorphine
AB-PINACA
- ARK AB-PINACA Assay
- Immunalysis Synthetic Cannabinoids-3 HEIA
Amphetamines
- Immunalysis Amphetamines HEIA
Barbiturates
- Immunalysis Barbiturates HEIA
Benzodiazepines
Benzoylecgonine (Cocaine Metab.)
- Immunalysis Benzoylecgonine HEIA
Buprenorphine
Cannabinoids
- Immunalysis Cannabinoids HEIA
Carisoprodol
- Immunalysis Carisoprodol HEIA
EDDP
- ARK EDDP Assay
- Immunalysis EDDP Specific HEIA
Ethylglucuronide (EtG)
Fentanyl
JWH-018
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-1 HEIA
Ketamine
Meperidine
- ARK Meperidine Assay
- Immunalysis Meperidine HEIA
Methamphetamine
- Immunalysis Methamphetamine HEIA
Methylphenidate-Metabolite
Opiates
- Immunalysis Opiates HEIA
Oxycodone
- Immunalysis Oxycodone HEIA
Phencyclidine (PCP)
- Immunalysis Phencyclidine HEIA
Pregabalin
Tapentadol
- Immunalysis Tapentadol HEIA
Tramadol
- ARK Diagnostics Tramadol Assay
- Immunalysis Tramadol HEIA
UR-144 / XLR-11
- ARK UR144/JWH-018 Assay
- Immunalysis Synthetic Cannabinoids-2 HEIA
Zolpidem
- Immunalysis Zolpidem HEIA
ARK Methylphenidate Metabolite Assay

This homogeneous enzyme immunoassay by ARK™ Diagnostics enables the quantitative determination of ritalinic acid, the primary metabolite of methylphenidate. It offers an efficient alternative to more time-consuming chromatographic methods and is ideal for monitoring patient compliance or detecting abuse. The assay is compatible with all major clinical chemistry analyzers and can be easily integrated into a lab’s existing drug screening routine.
- Highly specific detection of methylphenidate misuse in urine
- Rapid and sensitive screening method for the monitoring of patient compliance
- Cut-off 100 ng/mL
- Liquid, ready-to-use reagents, calibrators and controls
- Application protocols for all major clinical chemistry analyzers
Package Inserts